OGN Organon PE ratio, current and historical analysis
The PE ratio for Organon stock stands at 3.18 as of Feb 25, 2025. This is calculated based on the TTM EPS of $5.07 and the stock price of $16.13 per share. A decrease of 26% has been observed in the PE ratio compared to its average of 4.3 of the past four quarters.
OGN PE ratio history
Over the last four years, the average PE ratio of Organon has been 5.97. The current 3.18 price-to-earnings ratio is 47% less than the historical average. Analyzing the last four years, OGN's PE ratio reached its highest point in the Mar 2023 quarter at 8.03, with a price of $23.52 and an EPS of $2.93. The Dec 2023 quarter saw the lowest point at 3.6, with a price of $14.42 and an EPS of $4.01.
Organon PE ratio by year
Maximum annual increase: 35.55% in 2022
Maximum annual decrease: -53.49% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 3.6 | -53.49% | $14.42 | $4.01 |
| 2022 | 7.74 | 35.55% | $27.93 | $3.61 |
| 2021 | 5.71 | N/A | $30.45 | $5.33 |
| 2020 | N/A | N/A | N/A | $8.52 |
| 2019 | N/A | N/A | N/A | $12.69 |
| 2018 | N/A | N/A | N/A | N/A |
Organon PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 3.77 | -28.73% | $19.13 | $5.07 |
| Jun 2024 | 5.29 | 15.25% | $20.7 | $3.91 |
| Mar 2024 | 4.59 | 27.5% | $18.8 | $4.1 |
| Dec 2023 | 3.6 | -52.32% | $14.42 | $4.01 |
| Sep 2023 | 7.55 | 7.4% | $17.36 | $2.3 |
| Jun 2023 | 7.03 | -12.45% | $20.81 | $2.96 |
| Mar 2023 | 8.03 | 3.75% | $23.52 | $2.93 |
| Dec 2022 | 7.74 | 31.63% | $27.93 | $3.61 |
| Sep 2022 | 5.88 | -24.03% | $23.4 | $3.98 |
| Jun 2022 | 7.74 | 13.49% | $33.75 | $4.36 |
| Mar 2022 | 6.82 | 19.44% | $34.93 | $5.12 |
| Dec 2021 | 5.71 | 4.2% | $30.45 | $5.33 |
| Sep 2021 | 5.48 | 24.55% | $32.79 | $5.98 |
| Jun 2021 | 4.4 | N/A | $30.26 | $6.87 |
| Mar 2021 | N/A | N/A | N/A | $7.33 |
OGN average PE ratio chart
The current PE ratio of OGN is under its 3-year average.
OGN PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OGN Organon & Co | 3.07 | $4B |
| OPTN OptiNose Inc | N/A | $58.42M |
| OPK Opko Health Inc | N/A | $1.16B |
| ORGO Organogenesis Holdings Inc | N/A | $431.54M |
Frequently asked questions
What is Organon's PE ratio?
The price to earnings ratio for OGN stock as of Feb 25, 2025, stands at 3.18.
What is the 3-year average PE ratio for Organon (OGN)?
The 3-year average PE ratio for OGN stock is 6.19.
What is the highest PE ratio for OGN?
The highest quarterly PE ratio in the last four years has been 8.03 and it was in the Mar 2023 quarter.
How does the current PE ratio for OGN compare to its historical average?
The current PE ratio of OGN is 47% lower than the 4-year historical average.
Why is Organon's PE ratio so low?
A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.
How is OGN's PE ratio calculated (Organon PE ratio formula)?
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Feb 25, 2025), Organon's share price is $16.13. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $5.07. Therefore, Organon's price to earnings ratio for today is 3.18. PE RATIO(3.18) = STOCK PRICE($16.13) / TTM EPS($5.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.